医療関係者でない場合はコーポレートサイトへアクセスしてください
会員登録を完了しました
GSKproのご登録ありがとうございます。完了メールをご登録アドレス宛にお送りしております。
引き続き、GSKproの会員限定コンテンツをお楽しみください。
Event Registration successful
You now have sucesfully register for the event and you can also access the latest updates, events and resources.
In case you would like to receive SMS-reminders for the event you have registered, please scroll down to provide your mobile number.
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Event registration completed - pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.
Account activated - pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy the public content on our website
Event Account activated - pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy the public content on our website
In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.
アレックスビー筋注用は、日本初の組換えRSウイルスワクチン「アレックスビー筋注用」です。
これまでの60歳以上の成人に加え、RSウイルスによる感染症が重症化するリスクが高いと考えられる50歳以上の成人を対象として、用法及び用量追加に係る製造販売承認事項一部変更承認を取得しました。
2024/12/13 新規Webinar開催情報を追加しました。
2024/12/2 資材一覧/請求ページが新しくなりました。
2024/10/31 資材一覧/請求に「帯状疱疹疾患啓発相談サポートカード」他、新規資料を追加しました。
PM-JP-NA-WCNT-190010 2023.08
